Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 3/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 3/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methoxyamine SCHEMBL29077150 | 0.91 | ALDH1A1 (0.62) | ALDH1A1TDP1RAB9ANPC1RECQL | |
| SCHEMBL18365033 | 0.83 | TDP1 (0.60) | ALDH1A1TDP1RAB9ANPC1RECQL | |
| SCHEMBL16589005 | 0.83 | GPR35 (0.60) | ALDH1A1TDP1RAB9ANPC1RECQL | |
| SCHEMBL1982756 | 0.83 | HPGD (0.47) | ALDH1A1TDP1RAB9ANPC1RECQL | |
| SCHEMBL10212142 | 0.83 | TDP1 (0.44) | ALDH1A1TDP1RAB9ANPC1RECQL | |
| SCHEMBL535558 | 0.82 | ALDH1A1 (0.66) | ALDH1A1TDP1RAB9ANPC1RECQL | |
| SCHEMBL3391996 | 0.82 | ALDH1A1 (0.60) | ALDH1A1TDP1RAB9ANPC1RECQL | |
| SCHEMBL11209116 | 0.82 | ALDH1A1 (0.60) | ALDH1A1TDP1RAB9ANPC1RECQL | |
| SCHEMBL13665394 | 0.82 | ALDH1A1 (0.60) | ALDH1A1TDP1RAB9ANPC1RECQL | |
| SCHEMBL27760518 | 0.81 | ALDH1A1 (0.64) | ALDH1A1TDP1RAB9ANPC1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 428 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230373962-A1 | SUPRAMOLECULAR MOLECULES FOR THE TREATMENT OF CANCER | THE UNIVERSITY OF BIRMINGHAM (GB) | 2023-11-23 | — | — | US | claimed |
| CN-116854907-A | Polypeptide and nano-assembly and preparation method thereof | 中国科学技术大学 | 2023-10-10 | — | — | CN | claimed |
| WO-2022064066-A1 | SUPRAMOLECULAR MOLECULES FOR THE TREATMENT OF CANCER | THE UNIVERSITY OF BIRMINGHAM (GB) | 2022-03-31 | — | — | WO | claimed |
| CN-110407704-A | A kind of synthetic method of 3- formoxyl -2- nitrobenzene methyl | CHANGZHOU WATSON FINE CHEMICAL TECH CO LTD | 2019-11-05 | — | — | CN | claimed |
| CN-106460182-B | The method of bath compositions and the electroless for palladium | 安美特德国有限公司 | 2019-07-09 | — | — | CN | claimed |
| CN-103214432-B | Based on 5-methyl isophthalic acid, α-(replacement) hydroxyamide derivatives of 2,3-thiadiazoles and its production and use | NANKAI UNIVERSITY (CN) | 2015-08-26 | — | — | CN | claimed |
| CN-103214432-A | 5-methyl-1,2,3-thiadiazole based alpha-(substituted)oxyamide derivatives and preparation methods and application thereof | UNIV NANKAI | 2013-07-24 | — | — | CN | claimed |
| CN-103214475-A | Alpha-(substituted)oxyamide derivatives containing 4-methyl-1,2,3-thiadiazole and preparation methods and application thereof | UNIV NANKAI | 2013-07-24 | — | — | CN | claimed |
| EP-2206706-B1 | Method for producing acylamide compounds | SALTIGO GMBH (DE) | 2013-07-10 | — | — | EP | claimed |
| EP-2206705-B1 | Method for manufacturing benzomorpholine derivatives through hydration of o-nitrophenoxycarbonyl compounds | SALTIGO GMBH (DE) | 2013-03-13 | — | — | EP | claimed |
| US-20100222578-A1 | PROCESS FOR PREPARING ACYL AMIDE COMPOUNDS | SALTIGO GMBH (DE) | 2010-09-02 | — | — | US | claimed |
| EP-1670806-B9 | PROCESS FOR PREPARATION OF ESTERS OF 2-DIAZO-3-TRIMETHYLSILYLOXY-3-BUTENOIC ACID | RANBAXY LAB LTD (IN) | 2010-06-02 | — | — | EP | claimed |
| EP-1670806-B1 | PROCESS FOR PREPARATION OF ESTERS OF 2-DIAZO-3-TRIMETHYLSILYLOXY-3-BUTENOIC ACID | RANBAXY LAB LTD (IN) | 2010-01-06 | — | — | EP | claimed |
| EP-1283829-B1 | METHOD FOR MAKING ACYLAMIDES BY SYNTHESIZING AND ACYLATING BENZOXAZINES | SYNGENTA PARTICIPATIONS AG (CH) | 2007-06-27 | — | — | EP | claimed |
| EP-1670806-A1 | PROCESS FOR PREPARATION OF ESTERS OF 2-DIAZO-3-TRIMETHYLSILYLOXY-3-BUTENOIC ACID | Ranbaxy Laboratories Limited (IN) | 2006-06-21 | — | — | EP | claimed |
| US-6977299-B2 | Method for making acylamides by synthesizing and acylating benzoxazines | SYNGENTA CROP PROTECTION, INC. (US) | 2005-12-20 | — | — | US | claimed |
| WO-2005021560-A1 | PROCESS FOR PREPARATION OF ESTERS OF 2-DIAZO-3-TRIMETHYLSILYLOXY-3-BUTENOIC ACID | RANBAXY LABORATORIES LIMITED (IN) | 2005-03-10 | — | — | WO | claimed |
| US-20040044206-A1 | Method for making acylamides by synthesizing and acylating benzoxazines | SYNGENTA CROP PROTECTION, INC. | 2004-03-04 | — | — | US | claimed |
| EP-1283829-A1 | METHOD FOR MAKING ACYLAMIDES BY SYNTHESIZING AND ACYLATING BENZOXAZINES | Syngenta Participations AG (CH) | 2003-02-19 | — | — | EP | claimed |
| WO-2001090088-A1 | METHOD FOR MAKING ACYLAMIDES BY SYNTHESIZING AND ACYLATING BENZOXAZINES | SYNGENTA PARTICIPATIONS AG (CH) | 2001-11-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230373962-A1 | SUPRAMOLECULAR MOLECULES FOR THE TREATMENT OF CANCER | PCNA, DDX1, DDX18 | ALDH1A1 4454/4885TDP1 4223/4885RAB9A 1600/4885 |
| US-20040044206-A1 | Method for making acylamides by synthesizing and acylating benzoxazines | AADAC, NAAA, HDHD5 | ALDH1A1 767/4885TDP1 2695/4885RAB9A 4580/4885 |
| US-20100222578-A1 | PROCESS FOR PREPARING ACYL AMIDE COMPOUNDS | NISCH, KAT2A, NAAA | ALDH1A1 2838/4885TDP1 4497/4885RAB9A 742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.